Theranostics & Radionuclide Therapy-Certificate Course
Precision Oncology Through Molecular Imaging & Targeted Radiation
A comprehensive, practice-oriented certification program designed to build clinical, physics, and operational competence in theranostics and radionuclide therapy—from molecular targeting to patient-specific treatment workflows.
A Premium Certificate Course by Charkos Academy.
Program Overview
Theranostics represents the convergence of diagnostic imaging and targeted radionuclide therapy, enabling personalized cancer treatment based on molecular expression rather than anatomy alone.
This program provides a structured, end-to-end understanding of theranostics, covering:
- Molecular imaging foundations
- Radiopharmaceuticals and radionuclides
- Clinical workflows and patient selection
- Dosimetry and radiation safety
- Real-world oncology case studies
Designed to bridge theory, clinical application, and implementation.
INR 15,000 ( inclusive of GST)
EMI options available through the payment Gateway.
10 weeks (self-paced with live sessions)
Created by healthcare practitioners. Designed for real practices.
Why Choose Charkos Academy?
Charkos Academy delivers institution-grade medical education rooted in real-world healthcare practice.
This program offers:
- Structured, implementation-focused learning
- Faculty with clinical and academic expertise
- Assessment-driven knowledge building
- Practical tools, not just theory
- Designed for working professionals and postgraduate learners
What you will Learn
-
By the end of this program, participants will be able to:
- Explain the principles and clinical rationale of theranostics
- Identify diagnostic–therapeutic radionuclide pairs
- Understand radiopharmaceutical targeting mechanisms
- Interpret PET/CT and SPECT/CT for therapy planning
- Apply basic patient-specific dosimetry principles
- Follow clinical workflows for radionuclide therapy
- Address radiation safety and regulatory requirements
- Analyze real-world oncology case studies
Who is this course for?
Nuclear Medicine Physicians
Medical Physicists & Physics Residents
Nuclear Medicine Technologists
Oncology & Radiation Oncology Professionals
Postgraduate Students (Medical Physics / Nuclear Medicine/ Medical Oncology/ Surgical Oncology/ Radiation Oncology/ Gynaecology Oncology)
Radiopharmaceutical & Imaging Industry Professionals
Program Format
How You’ll Learn (Teaching Methodology)
Your learning experience is designed to balance scientific depth, clinical relevance, and practical application.
- Expert-led live online sessions with interactive Q&A
- Short explainer videos for concept reinforcement and revision
- Structured worksheets and guided exercises
- Real-world clinical case studies from nuclear medicine and oncology practice
- Step-by-step walkthroughs of clinical workflows and decision-making
- Access to recorded sessions for flexible, self-paced learning
Assessment & Certification
Your progress is supported through application-oriented assessments, not traditional exams.
- Participation in live sessions and discussions
- Module-wise assessments after every module
- Case-based or workflow-oriented assignments
- Final Capstone Project (clinical, dosimetry, or application focused)
🎓 Certificate in Theranostics & Radionuclide Therapy
Issued by Charkos Academy
Tools & Resources You Will Receive
- Comprehensive lecture slide decks
- Case study compendium
- Dosimetry calculation templates
- Clinical workflow SOP outlines
- Radiation safety checklists
- Regulatory reference documents
- Curated reading lists & landmark papers
- Lifetime LMS access to recordings & resources
Everything designed for immediate academic and clinical relevance.
Course Curriculum
COURSE STRUCTURE
(Modules & Learning Outcomes)
Module 1: Foundations of Theranostics
(Assessment included)
- Evolution of nuclear medicine to theranostics
- Molecular targeting and precision oncology
- Diagnostic–therapeutic radionuclide pairs
- Role of imaging biomarkers in treatment decisions
Module 2: Radiopharmaceuticals & Targeting Mechanisms
(Assessment included)
- Radiopharmaceutical design principles
- Peptides, antibodies, ligands, and small molecules
- Receptor expression and tumor heterogeneity
- Pharmacokinetics and biodistribution
Module 3: Radionuclides Used in Theranostics
(Assessment included)
- Diagnostic radionuclides: Ga-68, F-18, I-123
- Therapeutic radionuclides: Lu-177, I-131, Y-90, Ac-225
- Alpha vs beta emitters
- Production, supply chain, and logistics
Module 4: Imaging & Patient Selection
(Assessment included)
- PET/CT and SPECT/CT protocols
- Imaging for therapy planning
- Patient stratification and response prediction
- Limitations and pitfalls in image interpretation
Module 5: Radionuclide Therapy Clinical Workflow
(Assessment included)
- Patient preparation and consent
- Therapy administration protocols
- Ward setup and isolation practices
- Post-therapy imaging and follow-up
Module 6: Dosimetry in Theranostics
(Assessment included)
- Importance of patient-specific dosimetry
- Basics of MIRD schema
- Tumor dose vs organ dose
- Overview of dosimetry software tools
Module 7: Radiation Safety, Regulations & Ethics
(Assessment included)
- Radiation protection principles
- Patient, staff, and public safety
- National and international guidelines
- Waste management and contamination control
- Ethical considerations in radionuclide therapy
Module 8: Clinical Applications & Case Studies
(Assessment included)
- Neuroendocrine tumors (NETs)
- Prostate cancer (PSMA-based therapy)
- Thyroid cancer
- Emerging theranostic applications
Capstone Project (Final Evaluation)
Participants will complete one applied project, such as:
- Case-based theranostic treatment planning
- Introductory dosimetry analysis
- Clinical workflow or safety protocol design
- Critical review of a theranostic clinical study
Assessment & Certification
- Module-wise assessments after every module
- Capstone project evaluation
- Active participation in sessions
🎓 Certificate in Theranostics & Radionuclide Therapy
Issued by Charkos Academy
Gain Advantage From experts
Course Mentor:
Dr. Anupam Gauba
MBBS, DRM, FEBNM, Dip. CBNC, MBA(ISB)
Associate Director - Nuclear Medicine & PET/CT
PET/CT Specialist • Theranostics Expert • Internationally Trained Molecular Imaging Clinician
Dr. Anupam Gauba is a highly respected Nuclear Medicine physician with extensive expertise in PET/CT interpretation, molecular imaging, and targeted radionuclide therapy (theranostics). With years of clinical experience across high-volume oncology centres, he is recognised for his precision in diagnostic imaging and his leadership in advancing novel theranostic approaches.
A graduate of MBBS, followed by specialized training in DRM and DNB (Nuclear Medicine), Dr. Gauba has developed deep expertise in FDG, PSMA, DOTATATE PET/CT, SPECT/CT applications, and quantitative imaging. His clinical interests include Lu-177 DOTATATE, Lu-177 PSMA therapy, I-131 treatments, Y-90 procedures, and multidisciplinary integration of nuclear medicine with oncology, radiology, and radiation oncology.
Known for his clarity in teaching and practical approach to imaging interpretation, Dr. Gauba has trained numerous residents and fellows in recognizing physiological variants, avoiding interpretive errors, and applying standardised reporting systems such as Deauville, PERCIST, PSMA-RADS, and Krenning scoring. He is an active participant in tumour boards and contributes significantly to precision oncology decision-making.
Key Expertise:
- PET/CT (FDG, PSMA, DOTA)
- SPECT/CT Imaging
- Lu-177 PSMA & Lu-177 DOTATATE Therapy
- I-131 Thyroid Cancer Management
- Quantitative Imaging & SUV Interpretation
- Radiopharmaceutical Safety & Dosimetry
- Clinical case interpretation & tumour board decision-making
Dr. Anupam Gauba brings a blend of clinical excellence, teaching experience, and theranostic expertise—making him an invaluable mentor for learners seeking a strong foundation in modern Nuclear Medicine.
Course Mentor:
Dr. Aditi Khurana
MBBS, DRM, MD (Nuclear Medicine), RSO II, FANMB
Consultant – Nuclear Medicine • Radiation Safety Officer • Academic Trainer
Dr. Aditi Khurana is a distinguished Nuclear Medicine physician with extensive clinical, academic, and administrative experience. Her expertise spans SPECT/CT and PET/CT imaging, nuclear medicine therapies, radiation safety governance, teaching, and multidisciplinary healthcare leadership. She currently serves as Chief Medical Officer, Central Health Services, Ministry of Health & Family Welfare, Government of India, and is actively involved in Nuclear Medicine services at VMMC & Safdarjung Hospital, New Delhi.
With specialist training from renowned institutions including INMAS and AIIMS New Delhi, she has developed strong clinical proficiency in diagnostic imaging, functional organ evaluations, radionuclide therapies, and advanced novel tracer applications. She has independently reported over 10,000 nuclear medicine studies, offering exceptional diagnostic accuracy across cardiac, renal, endocrine, musculoskeletal, gastrointestinal and neuroimaging applications.
Dr. Aditi Khurana has also made significant contributions as a certified Radiation Safety Officer (Level II – AERB, India) with critical responsibilities in regulatory compliance, exposure monitoring, radiopharmaceutical handling, waste management, training, and institutional safety strategy.
Key Expertise:
- SPECT/CT Imaging & Whole-body Nuclear Medicine
- Cardiac Perfusion & Functional Imaging
- Renal, Thyroid, Parathyroid & Hepatobiliary Imaging
- Novel Radiotracers: PSMA, DOTATATE, FDG & Emerging Agents
- Radioiodine Therapy for Thyroid Cancer & Graves’ Disease
- Radiation Safety (Certified RSO Level II – AERB)
- Academic Teaching & Research Publications
- Hospital Emergency & Administrative Leadership
- Clinical decision-making & multidisciplinary care integration
Dr. Aditi Khurana brings a rare combination of clinical excellence, safety leadership, academic contribution, and institutional service—making her an invaluable mentor for learners in modern Nuclear Medicine practice.
How The Course Benifits You
⚛️
Build Advanced Clinical Competence
Understand theranostics beyond theory—right up to real-world workflows.
🧠
Strengthen Decision-Making Skills
Learn how imaging directly informs therapy selection and planning.
🔬
Bridge Physics & Clinical Practice
Connect dosimetry, safety, and molecular imaging into one framework.
🏥
Prepare for Future Clinical Adoption
Stay ahead as theranostics becomes a standard of care in oncology.
📈
Enhance Career OpprtunitiesValuable for hospital practice, academia, research and industry roles
🧭
Leave with a Personal Ayurveda Lifestyle Plan
By the end of the course, you’ll develop your own personalised wellness blueprint—a clear, practical guide to maintaining balance, health, and vitality long after the program ends.
Get Certified By Charkos Academy!
Yes! You will get a course completion certificate by Charkos Academy once you complete the course and the assignment!
FAQ
Is this program suitable for beginners?
This is an intermediate-to-advanced program. Basic knowledge of nuclear medicine, medical physics, or oncology is recommended.
Will this course include clinical case discussions?
Yes. Multiple real-world case studies are integrated into the curriculum.
Will I get recordings?
Yes—recordings are included
How much time do I need weekly?
About 2–3 hours/week, plus optional small daily practices.
Is dosimetry covered in detail?
The course covers foundational and practical dosimetry concepts, sufficient for clinical understanding and further specialization.
Will I receive a certificate?
Yes — a globally-usable digital certificate upon successful completion.
How long is the course accessible for?
The course is available with access for 60 days from the date of course purchase. You are welcome to watch the videos as many times as you like to master the learning.
Can my organisation book group training?
Yes — group packages and tailored delivery options are available for corporate teams with bulk discount coupons.
